MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem ROCE Ratio 2011-2026 | ENZ
Annual ROCE Ratio Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.04 | -31.53 | -31.26 | 1.01 | -52.02 | -26.69 | -8.64 | -1.54 | -4.23 | -8.72 | -16.04 | -37.51 | -31.77 | -14.09 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 | -52.02 | -20.36 |
Quarterly ROCE Ratio Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.61 | -13.42 | -57.54 | -98.71 | -109.47 | -68.26 | -73.3 | -34.22 | -17.61 | -5.02 | -1.8 | 6.34 | -7.73 | -4.15 | -34.83 | -37.09 | -38.96 | -50.28 | -41.79 | -18.16 | -8.42 | -5.84 | 8.64 | -23.73 | -21.52 | -14.33 | -12.46 | -5.27 | 9.63 | 8.91 | 25.04 | 24.35 | -0.48 | 10.79 | -19.06 | -6.78 | -6.68 | -25.04 | -26.49 | -45.72 | -49.56 | -50.14 | -61.59 | -62.09 | -52.04 | -51.63 | -39.02 | -38.29 | -38.69 | -35.2 | -26.06 | -17.64 | -5.23 | -7.5 | -4.92 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.04 | -109.47 | -25.39 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 17.35 | -6.52 % | $ 183 M |  China |
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 19.26 | 1.99 % | $ 558 M | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.02 | -1.05 % | $ 484 M | USA |
 |
Agilent Technologies
A
|
25.0 | $ 112.14 | -0.98 % | $ 34.1 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 140.19 | -2.13 % | $ 22.3 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 20.04 | -2.22 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 94.57 | -2.18 % | $ 6.38 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 420.05 | 0.21 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 048.98 | 0.68 % | $ 21.6 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 3.62 | - | $ 335 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.3 | -0.72 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 158.51 | -0.5 % | $ 7.86 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 19.0 | 0.37 % | $ 425 M | USA |
 |
Natera
NTRA
|
-76.66 | $ 185.77 | -5.66 % | $ 18.3 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 25.23 | -1.1 % | $ 23.9 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 5.84 | 0.34 % | $ 244 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 95.26 | -3.45 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
-33.71 | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 118.21 | 0.96 % | $ 9.75 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 49.69 | -6.16 % | $ 2.97 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 251.84 | -0.89 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 441.44 | -1.5 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.59 | 1.42 % | $ 212 M | Irlanda |
 |
Celcuity
CELC
|
-171.24 | $ 132.6 | -1.57 % | $ 6.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
7.05 | $ 332.1 | -0.33 % | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 8.36 | -0.83 % | $ 1.81 B | USA |